SEARCH

SEARCH BY CITATION

References

  • 1
    Smedile A, Niro GA, Rizzetto M. Hepatitis D virus. In: Richman, DD, Whitley, RJ, Hayden, FG, eds. Clinical Virology. NY, USA: Churchill Livingstone, 1997: 127384.
  • 2
    Rosina F, Conoscitore P, Cuppone R, et al. Changing pattern of chronic hepatitis D in southern Europe. Gastroenterology 1999; 117: 1616.
  • 3
    Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000; 32: 8247.
  • 4
    Farci P, Mandas A, Coiana A, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994; 330: 8894.
  • 5
    Rizzetto M, Rosina F. Hepatitis D virus: treatment. In: Zuckerman, AJ, Thomas, HC, eds. Viral Hepatitis. Edinburgh, UK: Churchill Livingstone, 1997: 38793.
  • 6
    Di Bisceglie AM, Martin P, Lisker-Melman M, et al. Therapy of chronic delta hepatitis with interferon alfa-2b. J Hepatol 1990; 11: S1514.
  • 7
    Berk L, de Man RA, Housset C, Berthelot P, Schalm SW. Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta. Prog Clin Biol Res 1991; 364: 41120.
  • 8
    Garripoli A, Di Marco V, Cozzolongo R, et al. Ribavirin treatment for chronic hepatitis D: a pilot study. Liver 1994; 14: 1547.
  • 9
    Rosina F, Conoscitore P, Smedile A, et al. Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study. Dig Liver Dis 2002; 34: 2859.
  • 10
    Smedile A, Casey JL, Cote PJ, et al. HDV viremia following orthotopic liver transplantation involves a typical HDV virion with hepatitis B surface antigen envelope. Hepatology 1998; 27: 17239.
  • 11
    Taylor JM. Structure and replication of hepatitis delta virus. Semin Virol 1990; 1: 13541.
  • 12
    Ishak KG. Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 2000; 113: 4055.
  • 13
    Smedile A, Rosina F, Saracco G, et al. Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology 1991; 13: 4136.
  • 14
    Ichimura H, Tamura I, Tsubakio T, et al. Influence of hepatitis delta virus superinfection on the clearance of hepatitis B virus (HBV) markers in HBV carriers in Japan. J Med Virol 1988; 26: 4955.
  • 15
    Pastore G, Monno L, Santantonio T, et al. Hepatitis B virus clearance from serum and liver after acute hepatitis delta virus superinfection in chronic HBsAg carriers. J Med Virol 1990; 31: 28490.
  • 16
    Liaw YF, Tsai SL, Sheen IS, et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 1998; 93: 3549.
    Direct Link:
  • 17
    Niro GA, Gravinese E, Martini E, et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. Liver 2001; 21: 2549.
  • 18
    Lau DT, Doo E, Park Y, et al. Lamivudine for chronic delta hepatitis. Hepatology 1999; 30: 5469.
  • 19
    Doong S-L, Tsai C-H, Schinazi RF, Liotta DC, Cheng Y-C. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci U S A 1991; 88: 84959.
  • 20
    Wu JC, Chen PJ, Kuo MY, et al. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 1991; 65: 1099104.
  • 21
    Wang CJ, Chen PJ, Wu JC, et al. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol 1991; 65: 66306.
  • 22
    Peek SF, Cote PJ, Jacob JR, et al. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-β, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax). Hepatology 2001; 33: 25466.
  • 23
    Bordier BB, Ohkanda J, Liu P, et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest 2003; 112: 40714.